Eur J Pharmacol 553, 141-145, (2006). Brammer, M. K., Gilmore, D. L., & Matsumoto, R. R. View abstract in PubMed Post navigationPreviousPrevious post:Sigma receptor type 1 gene expression variation in a group of Polish patients with Alzheimer’s disease and mild cognitive impairment.NextNext post:Sigma-1 receptor activation prevents intracellular calcium dysregulation in cortical neurons during in vitro ischemia.Related PostsAnavex Life Sciences to Present at the 30th Annual ROTH ConferenceMarch 9, 2018Anavex Life Sciences to Present New Preclinical Data at the 20th Annual Meeting of the American Society for Experimental Neurotherapeutics (ASENT)March 7, 2018Anavex Life Sciences to Present at Cowen and Company 38th Annual Health Care ConferenceMarch 6, 2018Anavex Life Sciences Strengthens Management Team and Board of DirectorsMarch 5, 2018
Anavex Life Sciences to Present New Preclinical Data at the 20th Annual Meeting of the American Society for Experimental Neurotherapeutics (ASENT)March 7, 2018
